JP2020511410A5 - - Google Patents

Download PDF

Info

Publication number
JP2020511410A5
JP2020511410A5 JP2019531241A JP2019531241A JP2020511410A5 JP 2020511410 A5 JP2020511410 A5 JP 2020511410A5 JP 2019531241 A JP2019531241 A JP 2019531241A JP 2019531241 A JP2019531241 A JP 2019531241A JP 2020511410 A5 JP2020511410 A5 JP 2020511410A5
Authority
JP
Japan
Prior art keywords
ethyl
tetrahydropyran
azepine
pyrazolo
spiro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019531241A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020511410A (ja
JP7008073B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/082424 external-priority patent/WO2018108910A1/en
Publication of JP2020511410A publication Critical patent/JP2020511410A/ja
Publication of JP2020511410A5 publication Critical patent/JP2020511410A5/ja
Application granted granted Critical
Publication of JP7008073B2 publication Critical patent/JP7008073B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019531241A 2016-12-12 2017-12-12 置換ピラゾロアゼピン-4-オンおよびそれらのホスホジエステラーゼ阻害剤としての使用 Expired - Fee Related JP7008073B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16203335 2016-12-12
EP16203335.1 2016-12-12
PCT/EP2017/082424 WO2018108910A1 (en) 2016-12-12 2017-12-12 Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors

Publications (3)

Publication Number Publication Date
JP2020511410A JP2020511410A (ja) 2020-04-16
JP2020511410A5 true JP2020511410A5 (https=) 2021-01-21
JP7008073B2 JP7008073B2 (ja) 2022-01-25

Family

ID=57542834

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019531241A Expired - Fee Related JP7008073B2 (ja) 2016-12-12 2017-12-12 置換ピラゾロアゼピン-4-オンおよびそれらのホスホジエステラーゼ阻害剤としての使用

Country Status (7)

Country Link
US (2) US11065257B2 (https=)
EP (1) EP3551632B1 (https=)
JP (1) JP7008073B2 (https=)
CN (1) CN110167944B (https=)
ES (1) ES2981006T3 (https=)
RU (1) RU2768746C2 (https=)
WO (1) WO2018108910A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3642210T3 (da) 2017-06-20 2024-12-09 Union Therapeutics As Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser
PT3724196T (pt) 2017-12-15 2023-01-13 Union Therapeutics As Azetidina di-hidrotienopiridinas substituídas e a sua utilização como inibidores de fosfodiesterase
GB202306662D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Dosage regimen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2803299B1 (fr) * 2000-01-05 2004-09-17 Warner Lambert Co NOUVELLES PYRAZOLO [4,3-e] DIAZEPINES SUBSTITUEES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION
WO2004098520A2 (en) 2003-05-01 2004-11-18 Irm Llc Compounds and compositions as protein kinase inhibitors
TW200745106A (en) 2005-10-03 2007-12-16 Astrazeneca Ab Chemical compounds
US7671069B2 (en) 2006-03-30 2010-03-02 Chemocentryx, Inc. Tricyclic, heteroaromatic compounds modulating CXCR4 and/ or CXCR7
ES2372320T3 (es) * 2006-11-15 2012-01-18 Vertex Pharmceuticals Incorporated Compuestos útiles como inhibidores de proteínas quinasas.
CA2676933C (en) * 2007-02-28 2015-09-29 Leo Pharma A/S Novel phosphodiesterase inhibitors
GB0704652D0 (en) 2007-03-09 2007-04-18 Syngenta Participations Ag Novel herbicides
US8637501B2 (en) 2009-07-01 2014-01-28 Albany Molecular Research, Inc. Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine MCH-1 antagonists, methods of making, and use thereof
WO2018108231A1 (en) 2016-12-12 2018-06-21 Leo Pharma A/S Substituted pyrazoloazepin-8-ones and their use as phosphodiesterase inhibitors
JP6850886B2 (ja) 2016-12-12 2021-03-31 レオ ファーマ アクティーゼルスカブ 置換ピラゾロアゼピン−4−オンおよびそれらのホスホジエステラーゼ阻害剤としての使用

Similar Documents

Publication Publication Date Title
US12528818B2 (en) Compositions and methods for inhibition of RAS
CN1902196B (zh) 噻唑衍生物
JP7611278B2 (ja) 金属酵素阻害剤化合物
AU2008322595B2 (en) Method of treating arthritis
EP2736904B1 (en) Oxazole and thiazole derivatives as selective protein kinase inhibitors (c-kit)
CA2918284A1 (en) Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core
CN116531380A (zh) 用于治疗癌症的2-杂芳基-3-氧代-2,3-二氢哒嗪-4-甲酰胺
RU2015154987A (ru) Гетероциклические производные
JP6706023B2 (ja) 線維症の小分子阻害剤
JP2020511410A5 (https=)
JP2016503785A5 (https=)
CN111108109A (zh) 取代的二氢噻吩并嘧啶及其作为磷酸二酯酶抑制剂的用途
JP2020536915A5 (https=)
JP2021501183A5 (https=)
JP2019532974A5 (https=)
RU2019121694A (ru) Замещенные пиразолоазепин-4-оны и их применение в качестве ингибиторов фосфодиэстеразы
CN110088108A (zh) 取代的吡唑并氮杂*-4-酮类及其作为磷酸二酯酶抑制剂的用途
CN106188027A (zh) 芳杂环类衍生物及其在药物中的应用
JP2024545552A (ja) Ripk1阻害剤として縮合したヘテロ環
KR101764458B1 (ko) 치환 피리딘 화합물
CN109476637A (zh) 杂环脯氨酰胺衍生物
KR20100021444A (ko) 플루오로퀴놀론을 사용하여 염증을 조절하기 위한 조성물 및 방법
JPWO2021092264A5 (https=)
WO2007043426A1 (ja) 皮膚炎治療剤
CN113563245A (zh) 取代的吡咯烷类化合物及其在药物中的应用